Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling

Journal of Immunology

Volumn 184, Issue 5, 2010, Pages 2410-2422

  Radziewicz, Henry ^a   Ibegbu, Chris C ^a   Hon, Huiming ^a   Bédard, Nathalie ^b   Bruneau, Julie ^b,c   Workowski, Kimberly A ^a   Knechtle, Stuart J ^a   Kirk, Allan D ^a   Larsen, Christian P ^a   Shoukry, Naglaa H ^b,c   Grakoui, Arash ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD38 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2; PROGRAMMED DEATH 1 RECEPTOR; RIBAVIRIN; STAT5 PROTEIN; APOPTOSIS REGULATORY PROTEIN; CD86 PROTEIN, HUMAN; LECTIN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LIVER; MALE; MOLECULE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ACUTE DISEASE; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; VIROLOGY;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2; LECTINS, C-TYPE; MALE; MIDDLE AGED; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TIME FACTORS;

EID: 77951925447     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902994     Document Type: Article

References (48)

1. Rehermann, B. 2009. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 119: 1745-1754.
2. Lechner, F., N. H. Gruener, S. Urbani, J. Uggeri, T. Santantonio, A. R. Kammer, A. Cerny, R. Phillips, C. Ferrari, G. R. Pape, and P. Klenerman. 2000. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30: 2479-2487.
3. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191: 1499-1512.
4. Gruener, N. H., F. Lechner, M. C. Jung, H. Diepolder, T. Gerlach, G. Lauer, B. Walker, J. Sullivan, R. Phillips, G. R. Pape, and P. Klenerman. 2001. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 75: 5550-5558. (Pubitemid 32488148)
5. Thimme, R., D. Oldach, K. M. Chang, C. Steiger, S. C. Ray, and F. V. Chisari. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194: 1395-1406.
6. Appay, V., P. R. Dunbar, M. Callan, P. Klenerman, G. M. Gillespie, L. Papagno, G. S. Ogg, A. King, F. Lechner, C. A. Spina, et al. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
7. Radziewicz, H., C. C. Ibegbu, H. Hon, M. K. Osborn, K. Obideen, M. Wehbi, G. J. Freeman, J. L. Lennox, K. A. Workowski, H. L. Hanson, and A. Grakoui. 2008. Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J. Virol. 82: 9808-9822.
8. Grabowska, A. M., F. Lechner, P. Klenerman, P. J. Tighe, S. Ryder, J. K. Ball, B. J. Thomson, W. L. Irving, and R. A. Robins. 2001. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur. J. Immunol. 31: 2388-2394.
9. + T cells in peripheral blood and liver using peptide-MHC tetramers. Proc. Natl. Acad. Sci. USA 96: 5692-5697.
10. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
11. Radziewicz, H., C. C. Ibegbu, M. L. Fernandez, K. A. Workowski, K. Obideen, M. Wehbi, H. L. Hanson, J. P. Steinberg, D. Masopust, E. J. Wherry, et al. 2007. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81: 2545-2553.
12. Golden-Mason, L., B. Palmer, J. Klarquist, J. A. Mengshol, N. Castelblanco, and H. R. Rosen. 2007. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J. Virol. 81: 9249-9258. (Pubitemid 47311467)
13. Nakamoto, N., D. E. Kaplan, J. Coleclough, Y. Li, M. E. Valiga, M. Kaminski, A. Shaked, K. Olthoff, E. Gostick, D. A. Price, et al. 2008. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134: 1927-1937, 1937.e1-2.
14. Urbani, S., B. Amadei, D. Tola, M. Massari, S. Schivazappa, G. Missale, and C. Ferrari. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80: 11398-11403. (Pubitemid 44706581)
15. Kasprowicz, V., J. Schulze Zur Wiesch, T. Kuntzen, B. E. Nolan, S. Longworth, A. Berical, J. Blum, C. McMahon, L. L. Reyor, N. Elias, et al. 2008. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J. Virol. 82: 3154-3160.
16. Azuma, M., H. Yssel, J. H. Phillips, H. Spits, and L. L. Lanier. 1993. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177: 845-850.
17. Wyss-Coray, T., D. Mauri-Hellweg, K. Baumann, F. Bettens, R. Grunow, and W. J. Pichler. 1993. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur. J. Immunol. 23: 2175-2180.
18. Jeannin, P., N. Herbault, Y. Delneste, G. Magistrelli, S. Lecoanet-Henchoz, G. Caron, J. P. Aubry, and J. Y. Bonnefoy. 1999. Human effectormemory T cells express CD86: a functional role in naive T cell priming. J. Immunol. 162: 2044-2048. (Pubitemid 29288823)
19. Sun, Z. W., Y. H. Qiu, Y. J. Shi, R. Tao, J. Chen, Y. Ge, Y. M. Hu, H. B. Ma, Q. Shi, and X. G. Zhang. 2005. Time courses of B7 family molecules expressed on activated T-cells and their biological significance. Cell. Immunol. 236: 146-153.
20. Prabhu Das, M. R., S. S. Zamvil, F. Borriello, H. L. Weiner, A. H. Sharpe, and V. K. Kuchroo. 1995. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur. J. Immunol. 25: 207-211.
21. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704.
22. Kinter, A. L., E. J. Godbout, J. P. McNally, I. Sereti, G. A. Roby, M. A. O'Shea, and A. S. Fauci. 2008. The common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J. Immunol. 181: 6738-6746.
23. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545. (Pubitemid 35291652)
24. Köchli, C., T. Wendland, K. Frutig, R. Grunow, S. Merlin, and W. J. Pichler. 1999. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals. Immunol. Lett. 65: 197-201.
25. Rosignoli, G., A. Cranage, C. Burton, M. Nelson, A. Steel, B. Gazzard, F. Gotch, and N. Imami. 2007. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients. AIDS 21: 1379-1381. (Pubitemid 46883500)
26. Abe, K., Y. Takasaki, C. Ushiyama, J. Asakawa, T. Fukazawa, M. Seki, M. Hirashima, M. Ogaki, and H. Hashimoto. 1999. Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus. J. Clin. Immunol. 19: 58-66.
27. Verwilghen, J., R. Lovis, M. De Boer, P. S. Linsley, G. K. Haines, A. E. Koch, and R. M. Pope. 1994. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J. Immunol. 153: 1378-1385. (Pubitemid 24228530)
28. Badr, G., N. Bédard, M. S. Abdel-Hakeem, L. Trautmann, B. Willems, J. P. Villeneuve, E. K. Haddad, R. P. Sékaly, J. Bruneau, and N. H. Shoukry. 2008. Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. J. Virol. 82: 10017-10031.
29. Cox, A. L., K. Page, J. Bruneau, N. H. Shoukry, G. M. Lauer, A. Y. Kim, H. R. Rosen, H. Radziewicz, A. Grakoui, D. S. Fierer, et al. 2009. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology 136: 26-31.
30. Tatari-Calderone, Z., R. T. Semnani, T. B. Nutman, J. Schlom, and H. Sabzevari. 2002. Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction. J. Immunol. 169: 6162-6169. (Pubitemid 36903461)
31. Hudrisier, D., and P. Bongrand. 2002. Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance. FASEB J. 16: 477-486. (Pubitemid 34273231)
32. Hudrisier, D., A. Aucher, A. L. Puaux, C. Bordier, and E. Joly. 2007. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells. J. Immunol. 178: 3637-3647. (Pubitemid 46417631)
33. Joly, E., and D. Hudrisier. 2003. What is trogocytosis and what is its purpose? Nat. Immunol. 4: 815. (Pubitemid 37098646)
34. O'Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7: 1-11.
35. Schweneker, M., D. Favre, J. N. Martin, S. G. Deeks, and J. M. McCune. 2008. HIV-induced changes in T cell signaling pathways. J. Immunol. 180: 6490-6500.
36. Bengsch, B., H. C. Spangenberg, N. Kersting, C. Neumann-Haefelin, E. Panther, F. von Weizsäcker, H. E. Blum, H. Pircher, and R. Thimme. 2007. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J. Virol. 81: 945-953. (Pubitemid 46067919)
37. Golden-Mason, L., J. R. Burton, Jr., N. Castelblanco, J. Klarquist, S. Benlloch, C. Wang, and H. R. Rosen. 2006. Loss of IL-7 receptor a-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 44: 1098-1109. (Pubitemid 44748361)
38. Urbani, S., B. Amadei, P. Fisicaro, D. Tola, A. Orlandini, L. Sacchelli, C. Mori, G. Missale, and C. Ferrari. 2006. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 44: 126-139. (Pubitemid 44049146)
39. Sawa, Y., Y. Arima, H. Ogura, C. Kitabayashi, J. J. Jiang, T. Fukushima, D. Kamimura, T. Hirano, and M. Murakami. 2009. Hepatic interleukin-7 expression regulates T cell responses. Immunity 30: 447-457.
40. Tsai, S. L., Y. F. Liaw, M. H. Chen, C. Y. Huang, and G. C. Kuo. 1997. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25: 449-458.
41. Smyk-Pearson, S., I. A. Tester, J. Klarquist, B. E. Palmer, J. M. Pawlotsky, L. Golden-Mason, and H. R. Rosen. 2008. Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help. J. Virol. 82: 1827-1837. (Pubitemid 351206931)
42. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662. (Pubitemid 37310924)
43. Semmo, N., C. L. Day, S. M. Ward, M. Lucas, G. Harcourt, A. Loughry, and P. Klenerman. 2005. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41: 1019-1028. (Pubitemid 40593910)
44. Folgori, A., E. Spada, M. Pezzanera, L. Ruggeri, A. Mele, A. R. Garbuglia, M. P. Perrone, P. Del Porto, E. Piccolella, R. Cortese, et al; Acute Hepatitis C Italian Study Group. 2006. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 55: 1012-1019.
45. Franceschini, D., M. Paroli, V. Francavilla, M. Videtta, S. Morrone, G. Labbadia, A. Cerino, M. U. Mondelli, and V. Barnaba. 2009. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J. Clin. Invest. 119: 551-564.
46. Manigold, T., and V. Racanelli. 2007. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect. Dis. 7: 804-813.
47. Radziewicz, H., R. M. Dunham, and A. Grakoui. 2009. PD-1 tempers Tregs in chronic HCV infection. J. Clin. Invest. 119: 450-453.
48. Tang, Q., and J. A. Bluestone. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244.